Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Rehab Management|July 30, 2009
Low back pain recoveryRobert Babb
The Biochemical Journal|November 26, 2002
SDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domainRobert Babb, Benjamin R Bowen
The Journal of Biological Chemistry|January 10, 2002
An mRNA splice variant of the AFX gene with altered transcriptional activityZhenyu Yang, James Whelan, Robert Babb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor ModelsJohn O DaSilva, Katie Yang, Andres E Perez Bay, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infectionKristen E Pascal, Christopher M Coleman, Alejandro O Mujica, et al.
Plos One|May 9, 2020
Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5Adrianna Latuszek, Yashu Liu, Olav Olsen, et al.
Scientific Reports|August 21, 2019
A novel bispecific antibody platform to direct complement activity for efficient lysis of target cellsJonathan W Cruz, Ermelinda Damko, Bhavika Modi, et al.
Neurobiology of Pain (Cambridge, Mass.)|December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis painSelin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2019
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding propertiesLynn E Macdonald, Karoline A Meagher, Matthew C Franklin, et al.
Scientific Reports|July 14, 2021
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuningLauric Haber, Kara Olson, Marcus P Kelly, et al.
Pageof 2